BCPC

Balchem Corp. has reported strong financial results, including record first-quarter consolidated sales, adjusted EBITDA, adjusted net earnings, and adjusted EPS for Q1 2026. Net sales for Q1 2026 were $270.7 million, an 8.1% increase year-over-year, with GAAP net earnings of $40.3 million and adjusted EBITDA of $74.3 million. For the full year 2025, Balchem reported record sales of $1.037 billion and record adjusted EBITDA of $274.9 million, and increased its dividend by a double-digit percentage. Management has cautioned about potential supply chain disruptions and modest margin compression due to geopolitical conflicts and petrochemical-based inflation. Balchem announced a global price increase across its Animal Nutrition and Health product portfolio, effective April 15, 2026, to address increased costs. BCPC's stock price has seen a 5.66% increase over the past six months, with a share price of $175.17 as of April 22, 2026.